Cogent Biosciences, Inc. (COGT) stock
COGTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$27.85+0.41 (+1.49%)
Close on Nov 17, 2026Market cap $4.83BP/E –Yield –
Cogent Biosciences price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Cogent Biosciences's price to sales ratio was 35.7× on Apr 30, 2021, against 0.6× a year earlier. Over the last 3 years it ranged from 0.5× to 58.4×, with a median of 7.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2021 | Apr 30, 2021 | 35.7× | +30.5 |
| 2020 | Dec 31, 2020 | 5.2× | +3.2 |
| 2019 | Dec 31, 2019 | 2.0× | −14.3 |
| 2018 | Dec 31, 2018 | 16.4× | – |
See a number that looks wrong?